Philip D. Gregory
2013 - Sangamo Biosciences
In 2013, Philip D. Gregory earned a total compensation of $1.6M as Senior Vice President, Research and Chief Scientific Officer at Sangamo Biosciences, a 61% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $168,438 |
|---|---|
| Option Awards | $598,878 |
| Salary | $385,000 |
| Stock Awards | $424,200 |
| Total | $1,576,516 |
Gregory received $598.9K in option awards, accounting for 38% of the total pay in 2013.
Gregory also received $168.4K in non-equity incentive plan, $385K in salary and $424.2K in stock awards.
Rankings
In 2013, Philip D. Gregory's compensation ranked 4,748th out of 12,286 executives tracked by ExecPay. In other words, Gregory earned more than 61.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,748 out of 12,286 | 61st |
Division Manufacturing | 1,632 out of 4,612 | 65th |
Major group Chemicals And Allied Products | 471 out of 1,462 | 68th |
Industry group Drugs | 330 out of 1,156 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 51 out of 196 | 74th |
Source: SEC filing on April 25, 2016.
Gregory's colleagues
We found four more compensation records of executives who worked with Philip D. Gregory at Sangamo Biosciences in 2013.